{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:56:19Z","timestamp":1790124979303,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115262","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T21:20:52Z","timestamp":1753305652000},"page":"115262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Inhibition of Skp2 enhances anti-tumor immunity of macrophages by regulating CD47 in gastric cancer"],"prefix":"10.1016","volume":"163","author":[{"given":"Kaizhao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115262_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/annonc\/mdw040","article-title":"Molecular classification of gastric cancer","volume":"27","author":"Chia","year":"2016","journal-title":"Annals of oncology\u202f: official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.intimp.2025.115262_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114012","article-title":"Gastric Cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115262_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2025.115262_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","article-title":"Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer","volume":"86","author":"Zeng","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107581","article-title":"Role of regulatory B cells in gastric cancer: latest evidence and therapeutics strategies","volume":"96","author":"Jing","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115262_bb0030","first-page":"1133","article-title":"Gastric cancer: diagnosis and treatment options","volume":"69","author":"Layke","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.intimp.2025.115262_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11864-020-00774-4","article-title":"Targeted therapies in advanced gastric Cancer","volume":"21","author":"Patel","year":"2020","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.intimp.2025.115262_bb0045","doi-asserted-by":"crossref","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115262_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-981-15-3266-5_9","article-title":"Functions of immune checkpoint molecules beyond immune evasion","volume":"1248","author":"Zhang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/cas.13194","article-title":"Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy","volume":"108","author":"Chikuma","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2025.115262_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051389","article-title":"Cancer immunotherapy: a focus on the regulation of immune checkpoints","volume":"19","author":"Shi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115262_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00109-015-1376-x","article-title":"Immunosuppressive cells in tumor immune escape and metastasis","volume":"94","author":"Liu","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.intimp.2025.115262_bb0070","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.2017.14155","article-title":"Targeting immune checkpoints in Cancer therapy","volume":"318","author":"Topalian","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2025.115262_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113365","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115262_bb0080","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/med.21675","article-title":"Skp2 in the ubiquitin-proteasome system: a comprehensive review","volume":"40","author":"Asmamaw","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2025.115262_bb0085","doi-asserted-by":"crossref","first-page":"1140452","DOI":"10.3389\/fonc.2023.1140452","article-title":"UPS: opportunities and challenges for gastric cancer treatment","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115262_bb0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10555-017-9697-6","article-title":"Proteasome-associated deubiquitinases and cancer","volume":"36","author":"Mofers","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.intimp.2025.115262_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biom11010060","article-title":"The ubiquitin-proteasome system in immune cells","volume":"11","author":"\u00c7etin","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2025.115262_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102310","article-title":"Ubiquitin proteasome system in immune regulation and therapeutics","volume":"67","author":"Bhat","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115262_bb0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112674118","article-title":"The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage","volume":"118","author":"De","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115262_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115262_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-00418-x","article-title":"Targeting the ubiquitination\/deubiquitination process to regulate immune checkpoint pathways","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115262_bb0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/1873-3468.12985","article-title":"E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer","volume":"592","author":"Wang","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2025.115262_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115262_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-020-1144-z","article-title":"Skp2 modulates proliferation, senescence and tumorigenesis of glioma","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2025.115262_bb0135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1100\/tsw.2010.89","article-title":"Regulation of Skp2 expression and activity and its role in cancer progression","volume":"10","author":"Chan","year":"2010","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.intimp.2025.115262_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","article-title":"The Skp2 pathway: a critical target for Cancer therapy","volume":"67","author":"Cai","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.20050559","article-title":"Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation","volume":"202","author":"Sarmento","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115262_bb0150","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.95.19.11324","article-title":"Human CUL-1 associates with the SKP1\/SKP2 complex and regulates p21(CIP1\/WAF1) and cyclin D proteins","volume":"95","author":"Yu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115262_bb0155","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.1831009100","article-title":"Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation","volume":"100","author":"Kamura","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115262_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao3810","article-title":"Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors","volume":"11","author":"Clement","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2025.115262_bb0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","article-title":"Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression","volume":"154","author":"Chan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115262_bb0170","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","article-title":"The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis","volume":"149","author":"Chan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115262_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1667\/RR2679.1","article-title":"Overexpression of SKP2 promotes the radiation resistance of esophageal squamous cell carcinoma","volume":"177","author":"Wang","year":"2012","journal-title":"Radiat. Res."},{"key":"10.1016\/j.intimp.2025.115262_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009444","article-title":"LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer","volume":"12","author":"Lv","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2025.115262_bb0185","article-title":"SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability","author":"Peng","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115262_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1158\/1535-7163.MCT-23-0173","article-title":"SKP2 knockout in Rb1\/p53-deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis","volume":"23","author":"Ferrena","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2025.115262_bb0195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115262_bb0200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.115262_bb0205","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.7150\/ijbs.60782","article-title":"CD47\/SIRP\u03b1 pathway mediates cancer immune escape and immunotherapy","volume":"17","author":"Jia","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115262_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","article-title":"SIRP\u03b1-CD47 immune checkpoint blockade in anticancer therapy","volume":"39","author":"Veillette","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2025.115262_bb0215","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153470","article-title":"Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47","volume":"133","author":"Hu","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115262_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100862","article-title":"Regulation of CD47 expression in cancer cells","volume":"13","author":"Huang","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.intimp.2025.115262_bb0225","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1021\/acs.jmedchem.2c01675","article-title":"Discovery of novel 1,3-Diphenylpyrazine derivatives as potent S-phase kinase-associated protein 2 (Skp2) inhibitors for the treatment of Cancer","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115262_bb0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s42003-023-04581-z","article-title":"RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation","volume":"6","author":"Zhang","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.intimp.2025.115262_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010029","article-title":"Targeting the ubiquitin-proteasome system and recent advances in Cancer therapy","volume":"13","author":"Spano","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115262_bb0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12272-023-01455-0","article-title":"Ubiquitin-proteasome system as a target for anticancer treatment-an update","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2025.115262_bb0245","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.115262_bb0250","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41419-023-06183-3","article-title":"The mechanism of linear ubiquitination in regulating cell death and correlative diseases","volume":"14","author":"Gao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115262_bb0255","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2025.115262_bb0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-020-00421-2","article-title":"Targeting ubiquitin signaling for cancer immunotherapy","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115262_bb0265","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1038\/s41467-022-34346-x","article-title":"Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115262_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005116","article-title":"FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2025.115262_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113362","article-title":"FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation","volume":"42","author":"Tian","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2025.115262_bb0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","article-title":"FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115262_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115262_bb0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cbpa.2014.10.011","article-title":"TNFR1-activated NF-\u03baB signal transduction: regulation by the ubiquitin\/proteasome system","volume":"23","author":"Wertz","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0295","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.115262_bb0300","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1038\/s41467-020-18245-7","article-title":"Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells","volume":"11","author":"Candas-Green","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115262_bb0305","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13045-019-0822-6","article-title":"Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer","volume":"12","author":"Pan","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115262_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.intimp.2025.115262_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-981-15-3266-5_13","article-title":"Regulation of Cancer immune checkpoint: mono- and poly-ubiquitination: tags for fate","volume":"1248","author":"Yao","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2025.115262_bb0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00018-021-04124-x","article-title":"ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis","volume":"79","author":"Li","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2025.115262_bb0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115262_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216758","article-title":"Unleashing the power of immune checkpoints: post-translational modification of novel molecules and clinical applications","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115262_bb0335","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.molcel.2015.05.010","article-title":"Skp2-mediated RagA ubiquitination elicits a negative feedback to prevent amino-acid-dependent mTORC1 Hyperactivation by recruiting GATOR1","volume":"58","author":"Jin","year":"2015","journal-title":"Mol. Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:12:13Z","timestamp":1757913133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925012524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":67,"alternative-id":["S1567576925012524"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115262","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Skp2 enhances anti-tumor immunity of macrophages by regulating CD47 in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115262"}}